| Meta-analysis of tumor-and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition K Litchfield, JL Reading, C Puttick, K Thakkar, C Abbosh, R Bentham, ... Cell 184 (3), 596-614. e14, 2021 | 548 | 2021 |
| Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Y Chu, E Dai, Y Li, G Han, G Pei, DR Ingram, K Thakkar, JJ Qin, M Dang, ... Nature Medicine, 1-13, 2023 | 56 | 2023 |
| Whole-genome sequencing uncovers the genomic determinants of therapeutic resistance to immune checkpoint blockade K Litchfield, B Simpson, H Cha, A Castro, R Bentham, L Ryan, M Dietzen, ... | | 2023 |
| Quantifying the impact of immunotherapy on RNA dynamics in cancer I Usaite, D Biswas, K Dijkstra, TBK Watkins, O Pich, C Puttick, M Angelova, ... Journal for Immunotherapy of Cancer 11 (11), 2023 | | 2023 |
| 7P PrimeCUTR: Identifying clinically relevant neoantigens in the untranslated regions of cancer genomes CC Sng, BS Simpson, J Van De Haar, H Cha, A Coulton, K Thakkar, ... Immuno-Oncology and Technology 16, 2022 | | 2022 |
| Exploring the microbial landscape of NSCLC through TRACERx K Thakkar, H Fu, S Veeriah, K Litchfield, C Swanton, ... Cancer Research 82 (12_Supplement), 3043-3043, 2022 | | 2022 |
| Non-classical sources of tumour specific antigen in checkpoint inhibitor response K Thakkar, D Qian, H Cha, TB Watkins, C Swanton, K Litchfield Cancer Research 82 (12_Supplement), 643-643, 2022 | | 2022 |
